Pauline Wimberger

2
h-index
2
Publications
3,413
Citations

Publications

2 shown

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Pembrolizumab monotherapy showed durable antitumour activity and manageable safety in patients with metastatic triple-negative breast cancer. We aimed to examine whether the add...

2020 The Lancet 1658 citations

Frequent Co-Authors

Researcher Info

h-index
2
Publications
2
Citations
3,413
Institution
Technische Universität Dresden

External Links

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.